UNSPSC 51282933: Olamufloxacin

This classification denotes a quinolone antibiotic with the molecular formula C20H23FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LJG8KL1435, chemically known as 3-quinolinecarboxylic acid, 5-amino-7-(7-amino-5-azaspiro(2,4)hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxo-, (s)- but generally known as olamufloxacin, which bears US NIH Compound Identifier 477670. European Medicines Agency schedules Olamufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03495MIG.

UNSPSC 51282933 Olamufloxacin is a Commodity code that nominally identifies a specific fluoroquinolone antibiotic, but recent state and local solicitations tagged with this code show little activity directly aligned with that pharmaceutical. The recent opportunities—naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, fire department medical and first aid supplies, and generic multi-source pharmaceuticals through a cooperative purchasing vehicle—span a much broader range of health-system procurement activity. This mismatch between the code's specific drug name and the generalized health procurement work actually being bought suggests the code sees minimal relevant recent activity, or that issuing bodies are applying it imprecisely to wider pharmacy and medical-supply categories. Procurement under this code does include state health departments, county health agencies, municipalities, and cooperative purchasing consortia serving multiple jurisdictions. The geographic footprint includes Florida (Seminole County), Texas (Texas Health and Human Services Commission), and multi-state cooperative purchasing through Minnesota (MMCAP, with participation from Oregon and other member states).

Recent representative solicitations include Seminole County, Florida's IFB 60459723LAS posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: date discrepancy in source); the City of Tampa's IFB 26P00145 posted March 25, 2026, for medical and first aid supplies for the Fire Department Rescue Division, with a bid deadline of March 13, 2026 and an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 posted January 20, 2026, for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, and awarded vendors to be provided to authorized wholesalers by May 15, 2026. The Texas Health and Human Services Commission RFI HHS0017013 posted April 3, 2026, sought vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program, representing exploratory procurement activity ahead of formal solicitation.